SCHEMBL5959577

SCHEMBL5959577

Cc1cc(SCC=C(c2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)c2ccc(-c3ccc(OC(F)(F)F)cc3)cc2)ccc1OCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.68
PPARA Q07869 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3270962 0.97 PPARD (0.72) PPARDPPARA
SCHEMBL3269394 0.94 PPARD (0.68) PPARDPPARA
SCHEMBL3269396 0.94 PPARD (0.68) PPARDPPARA
SCHEMBL5959517 0.92 PPARD (0.63) PPARDPPARA
SCHEMBL5959696 0.89 PPARD (0.68) PPARDPPARA
SCHEMBL5959329 0.88 PPARD (0.71) PPARDPPARA
SCHEMBL5959436 0.88 PPARD (0.74) PPARDPPARA
SCHEMBL5959375 0.87 PPARD (0.48) PPARDPPARA
SCHEMBL5959731 0.87 PPARD (0.78) PPARDPPARA
SCHEMBL5959547 0.87 PPARD (0.78) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091245-B2 Compounds, their preparation and use NOVO NOVDISK A/S (DK) 2006-08-15 US claimed
US-20040143006-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2004-07-22 US claimed
US-7091245-B2 Compounds, their preparation and use NOVO NOVDISK A/S (DK) 2006-08-15 US disclosed
EP-1537076-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR THERAPEUTICAL USE NOVO NORDISK A/S (DK) 2005-06-08 EP disclosed
US-20040143006-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2004-07-22 US disclosed
WO-2004022533-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR THERAPEUTICAL USE NOVO NORDISK A/S (DK) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040143006-A1 Novel compounds, their preparation and use PPARG, PPARD, PPARA PPARD 2/4885PPARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.